NATAN DAVID 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
NATAN DAVID
Director
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2025-02-26+700,000→ 700,000 totalExercise: $0.33From: 2025-02-26Exp: 2035-02-26→ Common Stock (700,000 underlying)
Footnotes (2)
- [F1]On February 26, 2025 (the "Grant Date"), the Reporting Person was granted 700,000 Non-Qualified Stock Options to purchased shares of common stock (the "Common Stock") of Cyclacel Pharmaceuticals, Inc. (the "Company") in consideration of his services as a director of the Company. The option grant became exercisable on the Grant Date.
- [F2]Includes shares of Common Stock previously reported in Table I of the Reporting Person's Form 4 filed on January 7, 2025, which were not issued by the Company and are being replaced with the option grant reported in this Form 4.